Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL

European Journal of Cancer - Tập 46 - Trang 1848-1855 - 2010
Kelly Vallance1, Wei Liu2, Belinda N. Mandrell3, John C. Panetta4, Jami S. Gattuso3, Marilyn Hockenberry5, Sue Zupanec6, Lei Yang4, Jie Yang7, Pamela S. Hinds8
1Departments of Hematology/Oncology, Cook Children’s Medical Center, Fort Worth, TX, USA
2Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA
3Division of Nursing Research, St. Jude Children’s Research Hospital, Memphis, TN, USA
4Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA
5Pediatric Nurse Practitioner Program, Texas Children’s Cancer Center, Houston, TX, USA
6The Hospital for Sick Children, Toronto, Canada
7Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN USA
8Department of Nursing Research, Children’s National Medical Center, Washington University, Washington, DC, USA

Tài liệu tham khảo

Pui, 2006, Treatment of acute lymphoblastic leukemia, N Engl J Med, 354, 166, 10.1056/NEJMra052603 Gaynon, 2000, Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995, Leukemia, 14, 2223, 10.1038/sj.leu.2401939 Veerman, 1996, High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group, J Clin Oncol, 14, 911, 10.1200/JCO.1996.14.3.911 Balis, 1987, Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia, J Clin Oncol, 5, 202, 10.1200/JCO.1987.5.2.202 Jones, 1991, Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia, Med Pediatr Oncol, 19, 269, 10.1002/mpo.2950190411 Czock, 2005, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids, Clin Pharmacokinet, 44, 61, 10.2165/00003088-200544010-00003 Richter, 1983, Pharmacokinetics of dexamethasone in children, Pediatr Pharmacol (New York), 3, 329 Yang, 2008, Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia, J Clin Oncol, 26, 1932, 10.1200/JCO.2007.13.8404 Drigan, 1992, Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia, Med Pediatr Oncol, 20, 13, 10.1002/mpo.2950200104 Hinds, 2007, Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia, Cancer, 110, 2321, 10.1002/cncr.23039 Stuart, 2005, Adverse psychological effects of corticosteroids in children and adolescents, Arch Dis Child, 90, 500, 10.1136/adc.2003.041541 Adam, 1983, Protein synthesis, bodily renewal and the sleep-wake cycle, Clin Sci (Lond), 65, 561, 10.1042/cs0650561 Akerstedt, 1980, Adrenocortical and gonadal steroids during sleep deprivation, Sleep, 3, 23, 10.1093/sleep/3.1.23 Mindell, 2003 Hart, 2005, Health-related quality of life among children presenting to a pediatric sleep disorders clinic, Behav Sleep Med, 3, 4, 10.1207/s15402010bsm0301_3 Sadeh, 2002, Sleep, neurobehavioral functioning, and behavior problems in school-age children, Child Dev, 73, 405, 10.1111/1467-8624.00414 Meeske, 2005, Prevalence and correlates of fatigue in long-term survivors of childhood leukemia, J Clin Oncol, 23, 5501, 10.1200/JCO.2005.03.210 Mindell, 1999, Developmental features of sleep, Child Adolesc Psychiatr Clin N Am, 8, 695, 10.1016/S1056-4993(18)30149-4 Meltzer, 2006, Sleep and sleep disorders in children and adolescents, Psychiatr Clin North Am, 29, 1059, 10.1016/j.psc.2006.08.004 Sadeh, 1995, The role of actigraphy in the evaluation of sleep disorders, Sleep, 18, 288, 10.1093/sleep/18.4.288 Sanford, 2008, Gender differences in sleep, fatigue, and daytime activity in a pediatric oncology sample receiving dexamethasone, J Pediatr Psychol, 33, 298, 10.1093/jpepsy/jsm110 Shafqat, 2005, Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment, Ann Oncol, 16, 1545, 10.1093/annonc/mdi267 Wang, 2002, Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma, J Clin Oncol, 20, 1319, 10.1200/JCO.20.5.1319 Wratten, 2004, Fatigue during breast radiotherapy and its relationship to biological factors, Int J Radiat Oncol Biol Phys, 59, 160, 10.1016/j.ijrobp.2003.10.008 Relling, 2004, Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia, J Clin Oncol, 22, 3930, 10.1200/JCO.2004.11.020 Evans, 1999, Pharmacogenomics: translating functional genomics into rational therapeutics, Science, 286, 487, 10.1126/science.286.5439.487 Ueda, 1999, Recent progress in P-glycoprotein research, Anticancer Drug Des, 14, 115 Huizenga, 1998, A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo, J Clin Endocrinol Metab, 83, 144, 10.1210/jc.83.1.144 Hinds, 1999, Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients, Cancer Nurs, 22, 277, 10.1097/00002820-199908000-00004 Hinds, 2000, An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer, Eur J Oncol Nurs, 4, 6, 10.1054/ejon.1999.0051 D’Argenio, 2008 Osawa, 1997, Molecular evidence for human alpha 2-HS glycoprotein (AHSG) polymorphism, Hum Genet, 99, 18, 10.1007/s004390050302 Inoue, 2008, A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity, Diabetes Res Clin Pract, 79, 164, 10.1016/j.diabres.2007.08.005 Francke, 2001, A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27, Hum Mol Genet, 10, 2751, 10.1093/hmg/10.24.2751 Kissebah, 2000, Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc Natl Acad Sci USA, 97, 14478, 10.1073/pnas.97.26.14478 Vionnet, 2000, Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24, Am J Hum Genet, 67, 1470, 10.1086/316887 Siddiq, 2005, A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians, Diabetes, 54, 2477, 10.2337/diabetes.54.8.2477 Stefan, 2006, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans, Diabetes Care, 29, 853, 10.2337/diacare.29.04.06.dc05-1938 Woltje, 2006, CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression, J Mol Endocrinol, 36, 261, 10.1677/jme.1.02001 Lee, 2004, A cytokine-based neuroimmunologic mechanism of cancer-related symptoms, Neuroimmunomodulation, 11, 279, 10.1159/000079408 Wood, 2006, Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines, Oncol Nurs Forum, 33, 535, 10.1188/06.ONF.535-542 Vgontzas, 2005, IL-6 and its circadian secretion in humans, Neuroimmunomodulation, 12, 131, 10.1159/000084844 Belluco, 2003, 174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer, Clin Cancer Res, 9, 2173 Hoffmann, 2001, Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes, Transplantation, 72, 1444, 10.1097/00007890-200110270-00019 Avila, 2008, Autoantigenic nuclear proteins of a clinically atypical renal vasculitis, J Autoimmune Dis, 5, 3, 10.1186/1740-2557-5-3